RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
  Cloning
  Genetic Disorders
  X Chromosome
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Genetics Channel

subscribe to Genetics newsletter
Latest Research : Genetics

   EMAIL   |   PRINT
New method identified the specific gene involved with high cholesterol

Sep 4, 2005 - 10:08:00 AM
"The potential to use this approach to address the causes of serious human diseases is enormous. This might well be a landmark publication."

 
[RxPG] Until now, the genetic causes of diseases such as cancer, heart disease, and diabetes, have proven very elusive. A new approach, reported in Elsevier's journal Genomics, may soon put an end to this. Scientists have successfully used this method to identify the specific gene involved with high cholesterol.

The genetics of some human diseases can be quite easily defined: a simple mutation in a single gene causes it to malfunction or be inactivated. The gene's mutation can then be shown to be the direct cause of the disease. Unfortunately, however, the genetic basis of some of the deadliest human diseases is far more complex than this often involving subtle changes to several genes on different chromosomes.

A recent paper published by Dr. Alessandra Cervino and colleagues in the journal Genomics describes a new method for identifying the elusive genes involved in such complex diseases. Using a mouse model system for human diseases, scientists have successfully used this new method to identify a gene called Insig2, which is directly involved in the control of blood cholesterol levels. This gene has been demonstrably linked with the causes of obesity, diabetes and atherosclerosis in mice. As Dr. Eric Schadt, of Rosetta Inpharmatics, LLC, a subsidiary of Merck & Co. remarked, "Using this new method we have identified a gene involved with high blood cholesterol in mice, and we fully expect the human equivalent to be just as significant. This opens new doors in the potential treatment or prevention of cardiovascular disease in humans."

This new method is also directly applicable to many other diseases in human beings. According to Dr. Mark S. Boguski, Editor-in-Chief of Genomics, "The potential to use this approach to address the causes of serious human diseases is enormous. This might well be a landmark publication."



Publication: Elsevier's journal Genomics
On the web: Genomics 

Advertise in this space for $10 per month. Contact us today.


Related Genetics News
Genetic study of bedbugs may help identify pesticide resistance genes
Novel method of database analysis to help identify responsible genes and diagnostic markers
Environmental influences can be passed down to the next generation
Gene found to be key in etiology of cleft palate
History, geography also seem to shape our genome
Induced pluripotent stem cell lines from pigs
Egg cells help extend life of sperms
Family of genes known as KRAB-ZFP regulate genes dealing with stress
New screening strategy increases Down's syndrome detection before birth
Can genetic research spur racist attitudes?

Subscribe to Genetics Newsletter

Enter your email address:


 Additional information about the news article
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in 71 offices worldwide publish more than 2,000 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc , a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

The full version of the article can be accessed via ScienceDirect or Genomics..
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)